OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
58 hedge funds and large institutions have $318M invested in Oyster Point Pharma, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
-3
Holders Change %
-4.92%
% of All Funds
1.01%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
8
Increased
20
Reduced
14
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$4.13M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.96M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.05M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$851K |
| 5 |
State Street
Boston,
Massachusetts
|
+$551K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.22M |
| 2 |
VVA
Vida Ventures Advisors
Boston,
Massachusetts
|
-$2.06M |
| 3 |
JPMorgan Chase & Co
New York
|
-$1.23M |
| 4 |
LP
Lexington Partners
New York
|
-$501K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$478K |
